(19)
(11) EP 2 483 314 A1

(12)

(43) Date of publication:
08.08.2012 Bulletin 2012/32

(21) Application number: 10768428.4

(22) Date of filing: 01.10.2010
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
C07K 16/22(2006.01)
A61P 35/00(2006.01)
C07K 16/18(2006.01)
(86) International application number:
PCT/EP2010/064695
(87) International publication number:
WO 2011/039370 (07.04.2011 Gazette 2011/14)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 02.10.2009 EP 09172137
03.09.2010 EP 10175316

(71) Applicant: Boehringer Ingelheim International GmbH
55216 Ingelheim am Rhein (DE)

(72) Inventors:
  • BORGES, Eric
    55216 Ingelheim Am Rhein (DE)
  • GSCHWIND, Andreas
    55216 Ingelheim Am Rhein (DE)
  • BOUCNEAU, Joachim
    9840 De Pinte (BE)
  • DE TAVERNIER, Evelyn
    B-9080 Beervelde (BE)
  • KOLKMAN, Joost
    B-9830 Sint-Martens-Latem (BE)
  • MERCHIERS, Pascal
    B-2460 Kasterlee (BE)
  • VAN HOORICK, Diane
    B-9270 Laarne (BE)

(74) Representative: Hammann, Heinz et al
Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173
55216 Ingelheim am Rhein
55216 Ingelheim am Rhein (DE)

   


(54) BISPECIFIC BINDING MOLECULES FOR ANTI-ANGIOGENESIS THERAPY